A Study of the CardioFocus Endoscopic Ablation System (HeartLight) in Patients with Atrial Fibrillation

Overview

About this study

The purpose of this study is to demonstrate the safety and effectiveness of the CardioFocus Endoscopic Ablation System with Adaptive Contact (HeartLight) in the treatment of atrial fibrillation by creating electrical isolation of the pulmonary veins.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Age 18 to 75 years
  • Paroxysmal atrial fibrillation
  • Failure of at least one AAD
  • Others

Exclusion Criteria

  • Overall good health as established by multiple criteria

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Fred Kusumoto, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20309829

Mayo Clinic Footer